Chemotherapy for lung cancer
Cancer, even in developed countries, is the cause of high death rates of patients. The fact is that cancer is not easy to detect and in the overwhelming majority of cases it is diagnosed at a stage when metastases that have penetrated into other organs leave little chance of survival.
But nevertheless, doctors use modern diagnostic tools in various combinations, they can detect cancer cells at an early stage of the disease and take measures to destroy them:
- By surgery;
- Radiation therapy;
- Chemotherapy.
Chemotherapy for lung cancer
To date, this type of treatment is recognized as the most effective for the destruction of tumor cells. It consists in taking medications inside the body orally or intravenously.
If the disease is detected late, at the 4th stage, when metastases have already settled in other organs, then even chemotherapy is powerless. However, this treatment can prolong the patient's life.
Side Effects of Chemistry and Therapy for Lung Cancer
As already mentioned, chemotherapy gives good results in early diagnosis of the disease. But even with a favorable outcome, it does not pass without leaving a trace, but has a certain negative effect on the body, from which they suffer:
- Bone marrow;
- Digestive organs;
- Blood cells;
- Hair fall out.
The negative effect of chemical drugs appears after the first course of treatment. Patients experience the following inconveniences:
- Unreasonable fatigue;
- Nausea and vomiting;
- Diarrhea;
- Discomfort in the mouth.
The next course of chemotherapy for lung cancer causes depression, signs of decreased hematopoiesis appear - hemoglobin and leukocytes decrease. Secondary infections are possible. The combination of such factors is not the best way to affect the quality of treatment.
Antiemetics are used to reduce side effects such as nausea. To prevent hair loss, they are cooled before the procedure.
Consequences of chemotherapy for lung cancer
Chemotherapy is the main type of cancer treatment, but, despite the high efficiency of the method, its consequences are difficult for the body to tolerate. This is explained by the fact that the modern pharmaceutical industry has not yet learned how to create drugs that can selectively act on certain groups of cells, in this case, only on cancer cells.
The author of the article: Bykov Evgeny Pavlovich | Oncologist, surgeon
Education: graduated from residency at the Russian Scientific Oncological Center. N. N. Blokhin "and received a diploma in the specialty" Oncologist"
